CoMind Secures Over $100 Million to Advance Breakthrough Brain-Monitoring Technology
CoMind’s latest $102.5 million funding round marks a major step forward for European health innovation. The London-based company is developing a non-invasive device that could make brain monitoring as routine as measuring blood pressure. Its success reflects the growing investor appetite Kylla observes for breakthrough medtech ventures that combine science, technology, and strong commercial potential. London-based health-technology company CoMind has…























































